Becton, Dickinson and Company BDX Medical — Cost of products sold

Other segment segments

Similar metrics at other companies

THRMMedical Segments — Cost of Goods Sold

$6.1M-2.8%

MDTMedical Surgical — Cost of products sold, excluding amortization of intangible assets

$964M+10.8%

JNJMedTech — Cost of products sold

$3.7B+11.3%

PGHealth Care — Cost of products sold

$1.28B+7.3%

NOVTMedical Solutions — Cost of Goods Sold

$71.73M+15.6%

ABTMedical Devices — Cost of products sold, excluding amortization of intangible assets

$1.81B+13.5%

Questions, answered.

What is Becton, Dickinson and Company's medical — cost of products sold?

Becton, Dickinson and Company (BDX) reported medical — cost of products sold of $1.37B in Q3 2025.

How has Becton, Dickinson and Company's medical — cost of products sold changed year-over-year?

Becton, Dickinson and Company's medical — cost of products sold increased by 9.0% year-over-year, from $1.25B to $1.37B.

What is the long-term trend for Becton, Dickinson and Company's medical — cost of products sold?

Over 2 years (2023 to 2025), Becton, Dickinson and Company's medical — cost of products sold has grown at a 7.6% compound annual growth rate (CAGR), from $4.72B to $5.46B.

What does medical — cost of products sold mean?

The direct costs associated with manufacturing and distributing the medical products sold within the segment. This includes raw materials, direct labor, and manufacturing overhead required to produce medical devices.